Chemopreventive effect of dietary flavonoid morin on chemically induced rat tongue carcinogenesis.
The modifying effects of dietary exposure of the flavonoid morin on 4-nitroquinoline 1-oxide (4-NQO)-induced tongue tumorigenesis, the activities of phase II detoxifying enzymes glutathione S-transferase (GST) and quinone reductase (QR) in liver and tongue, and cell proliferation activity in tongue were investigated in male F344 rats. At 7 weeks of age, all animals except those treated with morin alone and control group were given 4-NQO (20 ppm) in drinking water for 8 weeks to induce oral neoplasms. Starting 7 days before 4-NQO exposure, experimental groups were fed experimental diets containing morin (100 and 500 ppm) for 10 weeks ("initiation feeding"). Starting 1 week after the cessation of exposure to 4-NQO, other experimental groups given 4-NQO and a basal diet were given experimental diets for 22 weeks ("post-initiation feeding"). At week 32 week, "initiation feeding" of morin caused a significant reduction in the incidence of tongue carcinoma (by 44-100%). "Post-initiation feeding" with morin also significantly decreased the frequency of tongue carcinoma (by 44%). Morin feeding elevated liver GST and QR activities and GST activity in the anterior portion of tongue. Feeding with morin significantly lowered QR activity of the posterior part of the tongue. Dietary exposure to morin significantly decreased the proliferating cell nuclear antigen-positive index in the posterior portion. Also, morin feeding lowered tongue polyamine levels, especially in the "post-initiation feeding" group. Our results indicate that morin acts as a chemopreventive agent against tongue carcinogenesis induced by 4-NQO through modification of detoxifying enzyme activities and/or cell proliferation activities.
Kawabata
K
K
Department of Pathology, Gifu University School of Medicine, Gifu, Japan.
Tanaka
T
T
Honjo
S
S
Kakumoto
M
M
Hara
A
A
Makita
H
H
Tatematsu
N
N
Ushida
J
J
Tsuda
H
H
Mori
H
H
D015112:4-Nitroquinoline-1-oxide / Q000633:toxicity*; D000818:Animals; D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D015317:Biogenic Polyamines / Q000032:analysis; D004032:Diet; D005419:Flavonoids / Q000627:therapeutic use*; D005982:Glutathione Transferase / Q000378:metabolism; D008297:Male; D016660:NAD(P)H Dehydrogenase (Quinone) / Q000378:metabolism; D011230:Precancerous Conditions / Q000517:prevention & control; D018809:Proliferating Cell Nuclear Antigen / Q000032:analysis; D051381:Rats; D011916:Rats, Inbred F344; D014062:Tongue Neoplasms / Q000139:chemically induced / Q000517:prevention & control*; D047309:Flavones
D015112:4-Nitroquinoline-1-oxide; D016588:Anticarcinogenic Agents; D015317:Biogenic Polyamines; D005419:Flavonoids; D005982:Glutathione Transferase; D016660:NAD(P)H Dehydrogenase (Quinone); D018809:Proliferating Cell Nuclear Antigen; C008548:morin; D047309:Flavones